Spotlight on Pioglitazone in Type 2 Diabetes Mellitus

Author： Waugh John Keating Gillian M. Plosker Greg L. Easthope Stephanie Robinson Dean M.

ISSN： 1175-6349

Source： Treatments in Endocrinology, Vol.5, Iss.3, 2006-01, pp. : 189-191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Rosiglitazone in the Management of Type 2 Diabetes Mellitus

By Wagstaff A.J. Goa K.L.

Treatments in Endocrinology, Vol. 1, Iss. 6, 2002-01 ,pp. : 411-414

Adis International

Access to resources Recommend Favorite

Spotlight on Insulin Aspart in Type 1 and 2 Diabetes Mellitus

By Chapman T.M. Noble S. Goa K.L.

Treatments in Endocrinology, Vol. 2, Iss. 1, 2003-01 ,pp. : 71-76

Adis International

Access to resources Recommend Favorite

Spotlight on Insulin Glargine in Type 1 and 2 Diabetes Mellitus

By McKeage K. Goa K.L.

Treatments in Endocrinology, Vol. 1, Iss. 1, 2002-01 ,pp. : 55-58

Adis International

Access to resources Recommend Favorite

Improved Glycemic Control and Lipid Profile in a Randomized Study of Pioglitazone Compared with Acarbose in Patients with Type 2 Diabetes Mellitus

By Göke B.

Treatments in Endocrinology, Vol. 1, Iss. 5, 2002-01 ,pp. : 329-336

Adis International

Access to resources Recommend Favorite

Pioglitazone Ameliorates Endothelial Dysfunction in Those with Impaired Glucose Regulation among the First-Degree Relatives of Type 2 Diabetes Mellitus Patients

Medical Principles and Practice, Vol. 22, Iss. 2, 2012-09 ,pp. : 156-160

Karger

Access to resources Recommend Favorite